2007
DOI: 10.1016/j.biocel.2006.10.019
|View full text |Cite
|
Sign up to set email alerts
|

Caveolin-3 and eNOS colocalize and interact in ciliated airway epithelial cells in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
16
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 24 publications
3
16
0
Order By: Relevance
“…In resting vascular endothelial cells, NOS is maintained in an inactive state through interaction with caveolin proteins: caveolin-1 and -3, but not caveolin-2 inhibit the catalytic activity of nNOS, iNOS and eNOS, by direct binding of the CSD to a caveolin binding motif in the NOS proteins [66]. In ciliated airway epithelial cells of the rat, a similar interaction was recently described for caveolin-3 and eNOS, suggesting that regulatory caveolin-NOS interactions also exist in the airway epithelium [31]. Negative allosteric modulation of eNOS by caveolin-1 and-3 competes with positive allosteric modulation of eNOS by Ca 2+ /calmodulin and hsp90 complexes.…”
Section: Nitric Oxide Metabolismmentioning
confidence: 68%
See 1 more Smart Citation
“…In resting vascular endothelial cells, NOS is maintained in an inactive state through interaction with caveolin proteins: caveolin-1 and -3, but not caveolin-2 inhibit the catalytic activity of nNOS, iNOS and eNOS, by direct binding of the CSD to a caveolin binding motif in the NOS proteins [66]. In ciliated airway epithelial cells of the rat, a similar interaction was recently described for caveolin-3 and eNOS, suggesting that regulatory caveolin-NOS interactions also exist in the airway epithelium [31]. Negative allosteric modulation of eNOS by caveolin-1 and-3 competes with positive allosteric modulation of eNOS by Ca 2+ /calmodulin and hsp90 complexes.…”
Section: Nitric Oxide Metabolismmentioning
confidence: 68%
“…Caveolin-2 immunoreactivity showed a similar distribution pattern though caveolin-2 was in very low abundance in tracheal epithelial cells [30]. Though absent from human lung tissue, caveolin-3 was expressed in the rat airway epithelium throughout the bronchial tree [31]. This broad and heterogeneous expression profile in the lung suggests an important, but cell-type specific role for caveolae and caveolins in determining cellular responses in health and disease; this is confirmed by studies showing that caveolin-1 and caveolin-2 knockout mice have severe pulmonary abnormalities [6,23,32], and by other studies showing that aberrant caveolin-1/2 expression is involved in diseases such as idiopathic pulmonary fibrosis, lung cancer and pulmonary hypertension [33][34][35].…”
Section: Caveolin Expression In the Lungmentioning
confidence: 72%
“…Up until now, the presence of Cav-3 in ASMC has only been described in tracheal muscle in rat (19). Whereas these findings suggest Cav-3 to be distributed throughout all mammalian species, other groups reported an absence of Cav-3 in Fig.…”
Section: Discussionmentioning
confidence: 85%
“…Three Cav isoforms have been identified, Cav-1, Cav-2, and Cav-3, among which the presence of either Cav-1 or Cav-3 is essential for the formation of caveolae (33). Cav-1 is widely expressed, including ASMC (13,19,31), whereas Cav-3 is found primarily in striated (skeletal and cardiac) muscle and certain SMC (35). In the heart and urinary bladder, MR subtypes are functionally coupled to caveolins.…”
mentioning
confidence: 99%
“…The expression of Cav3 has been also reported in smooth muscle cells, astroglial cells (Ikezu et al, 1998), sinus endothelial cells in spleen (Uehara and Miyoshi, 2002), ciliated airway epithelial cells of the trachea and bronchial tree (Krasteva et al, 2007), and chondrocytes in the limb cartilage (Schwab et al, 1999(Schwab et al, , 2000. Although the precise function of Cav3 remains unclear, mutations or alterations of Cav3-expression are responsible for specific diseases such as cardiomyopathy, myodystrophy, and Alzheimer's disease (for review, see Quest et al, 2004).…”
mentioning
confidence: 99%